UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

NOTICE OF EFFECTIVENESS

Effective Date:April 30,
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more Akari Therapeutics Charts.
Akari Therapeutics (NASDAQ:AKTX)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more Akari Therapeutics Charts.

Akari Therapeutics Plc News

Kuehn Law Encourages VIVK, MINM, SDPI, and AKTX Investors to Contact Law Firm
Saturday 16 March 2024 (2 months ago) • PR Newswire (US)
Form 425 - Prospectuses and communications, business combinations
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Tuesday 12 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 425 - Prospectuses and communications, business combinations
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 425 - Prospectuses and communications, business combinations
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form 8-K - Current report
Wednesday 6 March 2024 (2 months ago) • Edgar (US Regulatory)
Form D - Notice of Exempt Offering of Securities
Wednesday 10 January 2024 (4 months ago) • Edgar (US Regulatory)
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Friday 5 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)
Form 3 - Initial statement of beneficial ownership of securities
Wednesday 3 January 2024 (4 months ago) • Edgar (US Regulatory)

More Akari Therapeutics Plc News Articles